292 related articles for article (PubMed ID: 25709061)
1. Barrier or carrier? Pulmonary surfactant and drug delivery.
Hidalgo A; Cruz A; Pérez-Gil J
Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):117-27. PubMed ID: 25709061
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications.
Hidalgo A; Cruz A; Pérez-Gil J
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1740-1748. PubMed ID: 28450046
[TBL] [Abstract][Full Text] [Related]
3. The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles.
Garcia-Mouton C; Hidalgo A; Cruz A; Pérez-Gil J
Eur J Pharm Biopharm; 2019 Nov; 144():230-243. PubMed ID: 31560956
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins.
Guagliardo R; Pérez-Gil J; De Smedt S; Raemdonck K
J Control Release; 2018 Dec; 291():116-126. PubMed ID: 30321577
[TBL] [Abstract][Full Text] [Related]
5. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
Schleh C; Rothen-Rutishauser B; Kreyling WG
Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
[TBL] [Abstract][Full Text] [Related]
6. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
7. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
Serrano AG; Pérez-Gil J
Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
[TBL] [Abstract][Full Text] [Related]
8. A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant Function.
Sørli JB; Da Silva E; Bäckman P; Levin M; Thomsen BL; Koponen IK; Larsen ST
Am J Respir Cell Mol Biol; 2016 Mar; 54(3):306-11. PubMed ID: 26524226
[TBL] [Abstract][Full Text] [Related]
9. [The mucociliary system of the lung--role of surfactants].
Gehr P; Im Hof V; Geiser M; Schürch S
Schweiz Med Wochenschr; 2000 May; 130(19):691-8. PubMed ID: 10846763
[TBL] [Abstract][Full Text] [Related]
10. Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.
Autilio C; Pérez-Gil J
Arch Dis Child Fetal Neonatal Ed; 2019 Jul; 104(4):F443-F451. PubMed ID: 30552091
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties of nanoparticles affecting their fate and the physiological function of pulmonary surfactants.
Liu Q; Guan J; Song R; Zhang X; Mao S
Acta Biomater; 2022 Mar; 140():76-87. PubMed ID: 34843949
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions in pulmonary surfactant films.
Pérez-Gil J
Biol Neonate; 2002; 81 Suppl 1():6-15. PubMed ID: 12011560
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy.
Lopez-Rodriguez E; Pérez-Gil J
Biochim Biophys Acta; 2014 Jun; 1838(6):1568-85. PubMed ID: 24525076
[TBL] [Abstract][Full Text] [Related]
14. Role of lipid ordered/disordered phase coexistence in pulmonary surfactant function.
Casals C; Cañadas O
Biochim Biophys Acta; 2012 Nov; 1818(11):2550-62. PubMed ID: 22659676
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona.
Hu G; Jiao B; Shi X; Valle RP; Fan Q; Zuo YY
ACS Nano; 2013 Dec; 7(12):10525-33. PubMed ID: 24266809
[TBL] [Abstract][Full Text] [Related]
16. [Effect of sulfur dioxide on surface activity of the pulmonary surfactants and ultrastructure of type II alveolocytes].
Zaiats' LM
Fiziol Zh (1994); 2004; 50(1):52-6. PubMed ID: 14965052
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary surfactants and their role in pathophysiology of lung disorders.
Akella A; Deshpande SB
Indian J Exp Biol; 2013 Jan; 51(1):5-22. PubMed ID: 23441475
[TBL] [Abstract][Full Text] [Related]
18. Exogenous surfactant as a drug delivery agent.
Haitsma JJ; Lachmann U; Lachmann B
Adv Drug Deliv Rev; 2001 Apr; 47(2-3):197-207. PubMed ID: 11311992
[TBL] [Abstract][Full Text] [Related]
19. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
Joshi N
Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
[No Abstract] [Full Text] [Related]
20. Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films.
Parra E; Pérez-Gil J
Chem Phys Lipids; 2015 Jan; 185():153-75. PubMed ID: 25260665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
